Trabectedin
What is Trabectedin Trabectedin is an alkylating agent indicated for the treatment of unresectable or metastatic liposarcoma and leiomyosarcoma in patients that had previously received anthracycline-containing chemotherapy. Neutropenic sepsis, hepatotoxicity, rhabdomyolysis, and cardiomyopathy have been reported with trabectedin use. Brand Name Yondelis Indications soft-tissue sarcoma Side Effects anemia anemia anorexia anorexia arthralgia asthenia capillary leak …